Top Markets
Coin of the day
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited

0950
Pozycja w akcjach #22620
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops,... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
Cena akcji
$0.1458359
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$85.87M
Zmiana (1 dzień)
-1.30%
Zmiana (1 rok)
-38.40%
Kraj
HK
Handel Lee's Pharmaceutical Holdings Limited (0950)

Kategoria

Cena 0950 z kapitalizacją rynkową B
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
0950
$0.1458359
Kapitalizacja rynkowa Lee's Pharmaceutical Holdings Limited(0950)
Kapitalizacja rynkowa: $85.87M
Na dzień August 2026 spółka Lee's Pharmaceutical Holdings Limited ma kapitalizację rynkową wynoszącą $85.87M. Według naszych danych, czyni to Lee's Pharmaceutical Holdings Limited 22620th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Lee's Pharmaceutical Holdings Limited od 2002 do 2026
0950 w porównaniu do 5 najpopularniejszych stocks
Cena za 0950 Aktywa B Kapitalizacja rynkowa B Wyniki
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$8,850.34 $85.87M
$5.211T +6,068,594.72%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,721.62 $85.87M
$4.547T +5,294,634.25%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,069.03 $85.87M
$4.162T +4,847,147.71%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$6,101.55 $85.87M
$3.593T +4,183,743.16%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$4,743.03 $85.87M
$2.793T +3,252,208.68%